Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Bio-based Hemostatic Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4661962
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Bio-based Hemostatic Powder market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Bio-based hemostatic powder is a hemostatic product made from natural biomaterials, designed to quickly control bleeding and promote wound healing. It is usually made of biomaterials such as plant extracts, chitosan, collagen, etc., and has good biocompatibility and degradability. Its working mechanism is to quickly stop bleeding by adsorbing blood, promoting platelet aggregation and accelerating blood clot formation. Bio-based hemostatic powder is widely used in trauma emergency treatment, surgery and other medical scenarios because its natural ingredients are friendly to the human body and can effectively reduce the risk of infection and complications.
This report is a detailed and comprehensive analysis for global Bio-based Hemostatic Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bio-based Hemostatic Powder market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Bio-based Hemostatic Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Bio-based Hemostatic Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Bio-based Hemostatic Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bio-based Hemostatic Powder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bio-based Hemostatic Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, Hemostasis, MedTrade Products, Lanhine Medical, Haiyuan Hairun, Yancheng Yankang Medical Equipment, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bio-based Hemostatic Powder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oxidized Cellulose
Polysaccharides
Other
Market segment by Application
Surgery
First Aid
Major players covered
Johnson & Johnson
Medtronic
Baxter
BioCer Entwicklungs-GmbH
BD
Hemostasis
MedTrade Products
Lanhine Medical
Haiyuan Hairun
Yancheng Yankang Medical Equipment
Success Bio-Tech
Beijing Aitekang Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bio-based Hemostatic Powder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bio-based Hemostatic Powder, with price, sales quantity, revenue, and global market share of Bio-based Hemostatic Powder from 2020 to 2025.
Chapter 3, the Bio-based Hemostatic Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bio-based Hemostatic Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bio-based Hemostatic Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bio-based Hemostatic Powder.
Chapter 14 and 15, to describe Bio-based Hemostatic Powder sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bio-based Hemostatic Powder Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Oxidized Cellulose
    • 1.3.3 Polysaccharides
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bio-based Hemostatic Powder Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Surgery
    • 1.4.3 First Aid
  • 1.5 Global Bio-based Hemostatic Powder Market Size & Forecast
    • 1.5.1 Global Bio-based Hemostatic Powder Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Bio-based Hemostatic Powder Sales Quantity (2020-2031)
    • 1.5.3 Global Bio-based Hemostatic Powder Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Bio-based Hemostatic Powder Product and Services
    • 2.1.4 Johnson & Johnson Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Johnson & Johnson Recent Developments/Updates
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Bio-based Hemostatic Powder Product and Services
    • 2.2.4 Medtronic Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medtronic Recent Developments/Updates
  • 2.3 Baxter
    • 2.3.1 Baxter Details
    • 2.3.2 Baxter Major Business
    • 2.3.3 Baxter Bio-based Hemostatic Powder Product and Services
    • 2.3.4 Baxter Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Baxter Recent Developments/Updates
  • 2.4 BioCer Entwicklungs-GmbH
    • 2.4.1 BioCer Entwicklungs-GmbH Details
    • 2.4.2 BioCer Entwicklungs-GmbH Major Business
    • 2.4.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product and Services
    • 2.4.4 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 BioCer Entwicklungs-GmbH Recent Developments/Updates
  • 2.5 BD
    • 2.5.1 BD Details
    • 2.5.2 BD Major Business
    • 2.5.3 BD Bio-based Hemostatic Powder Product and Services
    • 2.5.4 BD Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 BD Recent Developments/Updates
  • 2.6 Hemostasis
    • 2.6.1 Hemostasis Details
    • 2.6.2 Hemostasis Major Business
    • 2.6.3 Hemostasis Bio-based Hemostatic Powder Product and Services
    • 2.6.4 Hemostasis Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hemostasis Recent Developments/Updates
  • 2.7 MedTrade Products
    • 2.7.1 MedTrade Products Details
    • 2.7.2 MedTrade Products Major Business
    • 2.7.3 MedTrade Products Bio-based Hemostatic Powder Product and Services
    • 2.7.4 MedTrade Products Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 MedTrade Products Recent Developments/Updates
  • 2.8 Lanhine Medical
    • 2.8.1 Lanhine Medical Details
    • 2.8.2 Lanhine Medical Major Business
    • 2.8.3 Lanhine Medical Bio-based Hemostatic Powder Product and Services
    • 2.8.4 Lanhine Medical Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Lanhine Medical Recent Developments/Updates
  • 2.9 Haiyuan Hairun
    • 2.9.1 Haiyuan Hairun Details
    • 2.9.2 Haiyuan Hairun Major Business
    • 2.9.3 Haiyuan Hairun Bio-based Hemostatic Powder Product and Services
    • 2.9.4 Haiyuan Hairun Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Haiyuan Hairun Recent Developments/Updates
  • 2.10 Yancheng Yankang Medical Equipment
    • 2.10.1 Yancheng Yankang Medical Equipment Details
    • 2.10.2 Yancheng Yankang Medical Equipment Major Business
    • 2.10.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product and Services
    • 2.10.4 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Yancheng Yankang Medical Equipment Recent Developments/Updates
  • 2.11 Success Bio-Tech
    • 2.11.1 Success Bio-Tech Details
    • 2.11.2 Success Bio-Tech Major Business
    • 2.11.3 Success Bio-Tech Bio-based Hemostatic Powder Product and Services
    • 2.11.4 Success Bio-Tech Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Success Bio-Tech Recent Developments/Updates
  • 2.12 Beijing Aitekang Medical Technology
    • 2.12.1 Beijing Aitekang Medical Technology Details
    • 2.12.2 Beijing Aitekang Medical Technology Major Business
    • 2.12.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product and Services
    • 2.12.4 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Beijing Aitekang Medical Technology Recent Developments/Updates

3 Competitive Environment: Bio-based Hemostatic Powder by Manufacturer

  • 3.1 Global Bio-based Hemostatic Powder Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Bio-based Hemostatic Powder Revenue by Manufacturer (2020-2025)
  • 3.3 Global Bio-based Hemostatic Powder Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Bio-based Hemostatic Powder by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Bio-based Hemostatic Powder Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Bio-based Hemostatic Powder Manufacturer Market Share in 2024
  • 3.5 Bio-based Hemostatic Powder Market: Overall Company Footprint Analysis
    • 3.5.1 Bio-based Hemostatic Powder Market: Region Footprint
    • 3.5.2 Bio-based Hemostatic Powder Market: Company Product Type Footprint
    • 3.5.3 Bio-based Hemostatic Powder Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bio-based Hemostatic Powder Market Size by Region
    • 4.1.1 Global Bio-based Hemostatic Powder Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Bio-based Hemostatic Powder Consumption Value by Region (2020-2031)
    • 4.1.3 Global Bio-based Hemostatic Powder Average Price by Region (2020-2031)
  • 4.2 North America Bio-based Hemostatic Powder Consumption Value (2020-2031)
  • 4.3 Europe Bio-based Hemostatic Powder Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Bio-based Hemostatic Powder Consumption Value (2020-2031)
  • 4.5 South America Bio-based Hemostatic Powder Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Bio-based Hemostatic Powder Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Bio-based Hemostatic Powder Sales Quantity by Type (2020-2031)
  • 5.2 Global Bio-based Hemostatic Powder Consumption Value by Type (2020-2031)
  • 5.3 Global Bio-based Hemostatic Powder Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Bio-based Hemostatic Powder Sales Quantity by Application (2020-2031)
  • 6.2 Global Bio-based Hemostatic Powder Consumption Value by Application (2020-2031)
  • 6.3 Global Bio-based Hemostatic Powder Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Bio-based Hemostatic Powder Sales Quantity by Type (2020-2031)
  • 7.2 North America Bio-based Hemostatic Powder Sales Quantity by Application (2020-2031)
  • 7.3 North America Bio-based Hemostatic Powder Market Size by Country
    • 7.3.1 North America Bio-based Hemostatic Powder Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Bio-based Hemostatic Powder Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Bio-based Hemostatic Powder Sales Quantity by Type (2020-2031)
  • 8.2 Europe Bio-based Hemostatic Powder Sales Quantity by Application (2020-2031)
  • 8.3 Europe Bio-based Hemostatic Powder Market Size by Country
    • 8.3.1 Europe Bio-based Hemostatic Powder Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Bio-based Hemostatic Powder Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bio-based Hemostatic Powder Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Bio-based Hemostatic Powder Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Bio-based Hemostatic Powder Market Size by Region
    • 9.3.1 Asia-Pacific Bio-based Hemostatic Powder Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Bio-based Hemostatic Powder Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Bio-based Hemostatic Powder Sales Quantity by Type (2020-2031)
  • 10.2 South America Bio-based Hemostatic Powder Sales Quantity by Application (2020-2031)
  • 10.3 South America Bio-based Hemostatic Powder Market Size by Country
    • 10.3.1 South America Bio-based Hemostatic Powder Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Bio-based Hemostatic Powder Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bio-based Hemostatic Powder Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Bio-based Hemostatic Powder Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Bio-based Hemostatic Powder Market Size by Country
    • 11.3.1 Middle East & Africa Bio-based Hemostatic Powder Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Bio-based Hemostatic Powder Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Bio-based Hemostatic Powder Market Drivers
  • 12.2 Bio-based Hemostatic Powder Market Restraints
  • 12.3 Bio-based Hemostatic Powder Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bio-based Hemostatic Powder and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bio-based Hemostatic Powder
  • 13.3 Bio-based Hemostatic Powder Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bio-based Hemostatic Powder Typical Distributors
  • 14.3 Bio-based Hemostatic Powder Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Bio-based Hemostatic Powder. Industry analysis & Market Report on Bio-based Hemostatic Powder is a syndicated market report, published as Global Bio-based Hemostatic Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Bio-based Hemostatic Powder market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo